Cyclopharm Ltd has released a press release.
Advancing Molecular Imaging in NSW
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cyclopharm
- Dividend/Distribution - CYC
- Nuclear imaging trial aiming to clear up airway diagnosis
- CYC Entitlement Offer Closed
- CYC Entitlement Offer Booklet
- Entitlement Offer
Later from Cyclopharm
- Cyclopharm acquires European distribution business
- Technegas USFDA Clinical Trial - Patient Enrolment Underway
- CYC CEO Presentation 2017 Australian Microcap Conference
- 40 Patient Milestone Achieved For Technegas USFDA Trial
- Cyclopharm Acquires Scandinavian Distribution Business
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm